Peter Donachie

Peter Donachie has extensive work experience in the pharmaceutical and consulting industries. Peter is currently a Senior Principal at Solici, a position they have held since 2023. Prior to this, they worked as Director at Biometis Consulting Ltd starting from 2019. From 2020 to 2023, they served as the Director of Intelligence & Insight and Advisory at Prescient Healthcare Group. Before that, they held various roles at Ablynx, Kyowa Kirin International plc., Charles River Laboratories, and Inveresk Research. Their roles included Global Caplacizumab Launch Director, Global Commercial Lead, International Brands Manager, Marketing Manager, Global Product Development Manager, Development Planning & Finance Manager, Senior Account Manager, Business Coordinator, Study Director, and Research Scientist.

Peter Donachie completed their Bachelor of Science (BSc) in Life Sciences at Edinburgh Napier University from 1991 to 1997. Peter then pursued their Master of Business Administration (MBA) in Business at Edinburgh Napier University from 2001 to 2004. In 2008, they obtained a Postgraduate Certificate (PgCert) in Health Economics from the University of Aberdeen. No further information is available regarding their education at the University of Aberdeen.